serw-MX  [xml]  
 
    
 DeCS Categories

C23 Pathological Conditions, Signs and Symptoms .
C23.888 Signs and Symptoms .
C23.888.885 Skin Manifestations .
D04 Polycyclic Compounds .
D04.210 Fused-Ring Compounds .
D04.210.500 Steroids .
D04.210.500.247 Cholestanes .
D04.210.500.247.222 Cholestenes .
D04.210.500.247.222.222 Cholestadienes .
D04.210.500.247.222.222.347 Cholestadienols .
D04.210.500.247.222.222.347.389 Fusidic Acid .
D04.210.500.247.808 Sterols .
D04.210.500.247.808.489 Fusidic Acid .
D10 Lipids .
D10.570 Membrane Lipids .
D10.570.938 Sterols .
D10.570.938.515 Fusidic Acid .
D27 Chemical Actions and Uses .
D27.505 Pharmacologic Actions .
D27.505.519 Molecular Mechanisms of Pharmacological Action .
D27.505.519.186 Antimetabolites .
D27.505.519.186.071 Hypolipidemic Agents .
D27.505.519.186.071.202 Anticholesteremic Agents .
D27.505.519.186.071.202.370 Hydroxymethylglutaryl-CoA Reductase Inhibitors .
D27.505.519.389 Enzyme Inhibitors .
D27.505.519.389.370 Hydroxymethylglutaryl-CoA Reductase Inhibitors .
D27.505.954 Therapeutic Uses .
D27.505.954.557 Lipid Regulating Agents .
D27.505.954.557.500 Hypolipidemic Agents .
D27.505.954.557.500.202 Anticholesteremic Agents .
D27.505.954.557.500.202.370 Hydroxymethylglutaryl-CoA Reductase Inhibitors .
F03 Mental Disorders .
F03.084 Bipolar and Related Disorders .
F03.084.500 Bipolar Disorder .
SP9 Health Law .
SP9.040 Constitutional Law .
SP9.040.010 State .
 
 Terms
 Synonyms & Historicals		Documents
LILACS e MDL		 
Bipolar Disorder .
Mania .
Manic State .
Psychoses, Manic-Depressive .
Bipolar Affective Psychosis .
Bipolar Depression .
Bipolar Disorders .
Disorder, Bipolar .
Disorder, Manic .
Manias .
Manic Depressive Psychosis .
Manic Disorders .
Manic States .
Manic-Depressive Psychoses .
Psychoses, Bipolar Affective .
Psychoses, Manic Depressive .
Psychosis, Bipolar Affective .
Psychosis, Manic Depressive .
State, Manic .
States, Manic .
Depression, Bipolar .
Psychosis, Manic-Depressive .
Affective Psychosis, Bipolar .
Manic-Depressive Psychosis .
Manic Disorder .
A major affective disorder marked by severe mood swings (manic or major depressive episodes) and a tendency to remission and recurrence. .
1.00
 
State .
Organization of a people with their own territory and GOVERNMENT to perform individual and collective purposes, with sovereignty. .
0.66
 
Fusidic Acid .
Fucithalmic .
Fusidate Sodium .
Fusidic Acid, Sodium Salt .
Fusidin .
Silver Fusidate .
Sodium Fusidate .
Stanicide .
Acid, Fusidic .
Fusidate, Silver .
Fusidate, Sodium .
Sodium, Fusidate .
An antibiotic isolated from the fermentation broth of Fusidium coccineum. (From Merck Index, 11th ed). It acts by inhibiting translocation during protein synthesis. .
0.53
 
Hydroxymethylglutaryl-CoA Reductase Inhibitors .
Inhibitors, HMG-CoA Reductase .
Inhibitors, Hydroxymethylglutaryl-CoA .
Inhibitors, Hydroxymethylglutaryl-Coenzyme A .
Statins .
HMG CoA Reductase Inhibitors .
HMG-CoA Statins .
Hydroxymethylglutaryl CoA Reductase Inhibitors .
Hydroxymethylglutaryl-CoA Inhibitors .
Hydroxymethylglutaryl-Coenzyme A Inhibitors .
Inhibitors, HMG CoA Reductase .
Inhibitors, Hydroxymethylglutaryl CoA .
Inhibitors, Hydroxymethylglutaryl Coenzyme A .
Inhibitors, Hydroxymethylglutaryl-CoA Reductase .
Reductase Inhibitors, HMG-CoA .
Reductase Inhibitors, Hydroxymethylglutaryl-CoA .
Statins, HMG CoA .
HMG-CoA Reductase Inhibitors .
Statins, HMG-CoA .
Compounds that inhibit HMG-CoA reductases. They have been shown to directly lower cholesterol synthesis. .
0.52
 
Skin Manifestations .
Manifestation, Skin .
Manifestations, Skin .
Skin Manifestation .
Dermatologic disorders attendant upon non-dermatologic disease or injury. .
0.52